Balloon treatment for chronic sinusitis
Part of Ear, nose & throat clinical trials.
This trial tests a balloon coated with a medicine (paclitaxel) to treat chronic sinusitis. It may help reduce inflammation and improve sinus drainage in adults with long-lasting sinus problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have chronic sinusitis diagnosed by a doctor and confirmed with a CT scan.
- The CT scan shows disease in both sides of your sinuses, especially the ethmoid and frontal sinuses.
- You have moderate to severe symptoms, with a score of 30 or higher on a sinus symptom questionnaire.
- You have tried other treatments that did not work well, and you are a candidate for sinus surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special nose dressing that slowly releases a steroid to reduce inflammation and improve healing after sinus surgery for chronic sinusitis with or without nasal polyps.
This study tests whether balloon sinuplasty works better or more efficiently for people with long-lasting or repeatedly returning inflammation in the maxillary sinuses (side sinuses near your cheeks). It focuses on people who did not improve with the usual nose spray (topical steroid) or who meet specific “recurrent” episode patterns.
This trial tests a fully dissolvable stent that releases medication inside the sinuses after surgery. It is for patients with a specific type of sinusitis (eosinophilic) and nasal polyps who either need surgery or have had surgery and show early signs of inflammation returning.
This trial tests whether using a navigation system during balloon sinus surgery makes the procedure more accurate for people with chronic sinusitis. It may help improve outcomes for those who have not had sinus surgery before.
This study tests a new sinus stent that slowly releases medicine to treat chronic sinusitis in both nostrils. The goal is to see if it helps reduce symptoms and inflammation better than usual care.
This trial tests if a new drug (Stapokibart) combined with a sinus surgery improves symptoms like nasal congestion, discharge, and loss of smell in people with type 2 chronic sinusitis.
Hear when a new Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.